Loading, Please Wait...
MORRISVILLE, N.C., April 18, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it won the first ever Association for Clinical Research Professionals (ACRP) Challenge for Sponsors and CROs. The competition, which was conducted at the ACRP 2019 Annual Conference in Nashville, Tennessee, tested competitors’ ability to create solutions to real-world scenarios in real-time.
“The All-Stars format provided a showcase for the collaborative problem-solving approach we bring to customer challenges every day,” said Paul Colvin, President, Syneos Health Clinical Solutions. “We are incredibly proud of the cross-functional Syneos Health team that mobilized to deliver stand-out solutions to complex scenarios in the high-pressure challenge. The team is a strong representation of the culture we’ve created at Syneos Health that thrives on cross-company insights sharing to speed the delivery of therapies to market.”
The winning Syneos Health team of All-Stars represented the company’s clinical offerings, one of the broadest ranges of traditional and non-traditional capabilities that can be custom fit to meet customer goals across the entire asset portfolio. The team included Christy Macias, Senior Director, Talent Acquisition (who also served as team leader); Amy Larrison, Executive Director, Clinical Development; Jennifer Ripple, Associate Director, Clinical Operations; Wayne Wise, Associate Director, Clinical Operations; Katie Andrews, Project Manager II; and Katey Stazzone Senior Project Manager.
Syneos Health competed against four other teams of all-star talent from top sponsor companies and CROs. During the one-day competition, teams were provided with three real-world scenarios and presented solutions to a judging panel of industry leaders from across the clinical research spectrum. Teams were judged on their ability to work together and collaboratively solve problems, while exemplifying operational efficiency, teamwork, effectiveness, cost constraint and communication.
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com or subscribe to our podcast.
|Investor Relations Contact:||Press/Media Contact:|
|Ronnie Speight||Danielle DeForge|
|Senior Vice President, Investor Relations||Executive Director, External Communications|
|+1 919 745 2745||+1 202 210 5992|